Teva Pharmaceuticals International GmbH et al v. Accord Healthcare Inc. > Summary
Court Case Number 1:21-cv-00952
Filing Date Jun 29, 2021
Termination Date Dec 12, 2022
Court Delaware District Court
Status Dismissed - Other
JudgesColm F. Connolly
Plaintiff Attorneys
27TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Stephen B. Brauerman
Bayard, P.A.
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Ronald P. Golden III
Bayard, P.A.
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Adam D. Harber
Williams & Connolly
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Ben V. Picozzi
Williams & Connolly
Cephalon (Teva)
Attorney Name: David I. Berl
Williams & Connolly
Cephalon (Teva)
Attorney Name: Stephen B. Brauerman
Bayard, P.A.
Cephalon (Teva)
Attorney Name: Ronald P. Golden III
Bayard, P.A.
Cephalon (Teva)
Attorney Name: Adam D. Harber
Williams & Connolly
Cephalon (Teva)
Attorney Name: Ben V. Picozzi
Williams & Connolly
Eagle Pharmaceuticals, Inc.
Attorney Name: Alexandra M. Joyce
McCarter & English
Eagle Pharmaceuticals, Inc.
Attorney Name: Daniel M. Silver
McCarter & English
Eagle Pharmaceuticals, Inc.
Attorney Name: Angela Whitesell
McCarter & English
Eagle Pharmaceuticals, Inc.
Attorney Name: Jennifer Koh
Latham & Watkins
Eagle Pharmaceuticals, Inc.
Attorney Name: Alex M. Grabowski
Latham & Watkins
Eagle Pharmaceuticals, Inc.
Attorney Name: Marc N. Zubick
Latham & Watkins
Eagle Pharmaceuticals, Inc.
Attorney Name: Daniel J. Brown
McCarter & English
Eagle Pharmaceuticals, Inc.
Attorney Name: Kenneth G. Schuler
Latham & Watkins
Eagle Pharmaceuticals, Inc.
Attorney Name: Angela Whitesell
DLA Piper
Eagle Pharmaceuticals, Inc.
Attorney Name: David F. Kowalski
Latham & Watkins
Cephalon (Teva)
Attorney Name: Scott L. Tarriff
Eagle Pharmaceuticals, Inc.
Cephalon (Teva)
Attorney Name: Philip Christopher Buxton
Eagle Pharmaceuticals, Inc.
Cephalon (Teva)
Attorney Name: Anthony Drager
Teva Pharmaceuticals
Cephalon (Teva)
Attorney Name: Nagesh R. Palepu
Teva Pharmaceuticals
Cephalon (Teva)
Attorney Name: Srikanth Sundaram
Eagle Pharmaceuticals, Inc.
Cephalon (Teva)
Attorney Name: Daniel P. Shanahan
Cephalon (Teva)
Attorney Name: Daniel P. Shanahan
Defendant Attorneys
8ACCORD HEALTHCARE USA
Attorney Name: Neal Seth
Wiley Rein LLP
ACCORD HEALTHCARE USA
Attorney Name: Stamatios Stamoulis
Stamoulis & Weinblatt
ACCORD HEALTHCARE USA
Attorney Name: Wesley E. Weeks
Wiley Rein LLP
ACCORD HEALTHCARE USA
Attorney Name: Corey J. Weinstein
Wiley Rein LLP
ACCORD HEALTHCARE USA
Attorney Name: Nitin Patel
Intas Pharmaceuticals Ltd.
ACCORD HEALTHCARE USA
Attorney Name: Ajeet Singh
Intas Pharmaceuticals Ltd.
ACCORD HEALTHCARE USA
Attorney Name: Alpesh Pathak
Intas Pharmaceuticals Ltd.
ACCORD HEALTHCARE USA
Attorney Name: Sabita Nair
ACCORD HEALTHCARE USA
Counter Defendant
45Cephalon (Teva)
Attorney Name: David I. Berl
Williams & Connolly
Cephalon (Teva)
Attorney Name: Stephen B. Brauerman
Bayard, P.A.
Cephalon (Teva)
Attorney Name: Ronald P. Golden III
Bayard, P.A.
Cephalon (Teva)
Attorney Name: Adam D. Harber
Williams & Connolly
Cephalon (Teva)
Attorney Name: Ben V. Picozzi
Williams & Connolly
Eagle Pharmaceuticals, Inc.
Attorney Name: Stephen B. Brauerman
Bayard, P.A.
Eagle Pharmaceuticals, Inc.
Attorney Name: Ronald P. Golden III
Bayard, P.A.
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: David I. Berl
Williams & Connolly
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Stephen B. Brauerman
Bayard, P.A.
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Ronald P. Golden III
Bayard, P.A.
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Adam D. Harber
Williams & Connolly
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Ben V. Picozzi
Williams & Connolly
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Angela X. Gao
Williams & Connolly
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Daniel P. Shanahan
Williams & Connolly
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Emily S. Dibenedetto
Shaw Keller LLP
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Stephen B. Brauerman
Bayard, P.A.
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Adam D. Harber
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Angela X. Gao
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Ben V. Picozzi
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: David I. Berl
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Ronald P. Golden III
Bayard, P.A.
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Stephen B. Brauerman
Bayard, P.A.
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Adam D. Harber
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Ben V. Picozzi
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: David I. Berl
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Ronald P. Golden III
Bayard, P.A.
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Ronald P. Golden III
Bayard, P.A.
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Stephen B. Brauerman
Bayard, P.A.
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Stephen B. Brauerman
Bayard, P.A.
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Angela X. Gao
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Ronald P. Golden III
Bayard, P.A.
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Stephen B. Brauerman
Bayard, P.A.
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Adam D. Harber
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Angela X. Gao
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Ben V. Picozzi
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: David I. Berl
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Ronald P. Golden III
Bayard, P.A.
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Stephen B. Brauerman
Bayard, P.A.
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Ronald P. Golden III
Bayard, P.A.
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Stephen B. Brauerman
Bayard, P.A.
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Adam D. Harber
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Angela X. Gao
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Ben V. Picozzi
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: David I. Berl
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Ronald P. Golden III
Bayard, P.A.
Counter Claimant
13ACCORD HEALTHCARE USA
Attorney Name: Neal Seth
Wiley Rein LLP
ACCORD HEALTHCARE USA
Attorney Name: Stamatios Stamoulis
Stamoulis & Weinblatt
ACCORD HEALTHCARE USA
Attorney Name: Wesley E. Weeks
Wiley Rein LLP
ACCORD HEALTHCARE USA
Attorney Name: Corey J. Weinstein
Wiley Rein LLP
ACCORD HEALTHCARE USA
Attorney Name: Corey J. Weinstein
ACCORD HEALTHCARE USA
Attorney Name: Neal Seth
ACCORD HEALTHCARE USA
Attorney Name: Stamatios Stamoulis
Stamoulis & Weinblatt
ACCORD HEALTHCARE USA
Attorney Name: Wesley E. Weeks
ACCORD HEALTHCARE USA
Attorney Name: Stamatios Stamoulis
Stamoulis & Weinblatt
ACCORD HEALTHCARE USA
Attorney Name: Corey J. Weinstein
ACCORD HEALTHCARE USA
Attorney Name: Neal Seth
ACCORD HEALTHCARE USA
Attorney Name: Stamatios Stamoulis
Stamoulis & Weinblatt
ACCORD HEALTHCARE USA
Attorney Name: Wesley E. Weeks
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 11103483 | Formulations of bendamustine | Aug 31, 2021 |
| 10052385 | Formulations of bendamustine | Aug 21, 2018 |
| 10010533 | Formulations of bendamustine | Jul 3, 2018 |
| 09597397 | Formulations of bendamustine | Mar 21, 2017 |
| 09597398 | Formulations of bendamustine | Mar 21, 2017 |
| 09597399 | Formulations of bendamustine | Mar 21, 2017 |
| 09579384 | Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration | Feb 28, 2017 |
| 09572796 | Formulations of bendamustine | Feb 21, 2017 |
| 09572797 | Formulations of bendamustine | Feb 21, 2017 |
| 09572887 | Formulations of bendamustine | Feb 21, 2017 |
| 09265831 | Formulations of bendamustine | Feb 23, 2016 |
| 09144568 | Formulations of bendamustine | Sep 29, 2015 |
| 09034908 | Formulations of bendamustine | May 19, 2015 |
| 09000021 | Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration | Apr 7, 2015 |
| 08609707 | Formulations of bendamustine | Dec 17, 2013 |
